Correlation Between Consilium Acquisition and Da32 Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Consilium Acquisition and Da32 Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Consilium Acquisition and Da32 Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Consilium Acquisition I and Da32 Life Science, you can compare the effects of market volatilities on Consilium Acquisition and Da32 Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Consilium Acquisition with a short position of Da32 Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Consilium Acquisition and Da32 Life.

Diversification Opportunities for Consilium Acquisition and Da32 Life

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Consilium and Da32 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Consilium Acquisition I and Da32 Life Science in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Da32 Life Science and Consilium Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Consilium Acquisition I are associated (or correlated) with Da32 Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Da32 Life Science has no effect on the direction of Consilium Acquisition i.e., Consilium Acquisition and Da32 Life go up and down completely randomly.

Pair Corralation between Consilium Acquisition and Da32 Life

If you would invest  1,150  in Consilium Acquisition I on December 29, 2024 and sell it today you would earn a total of  11.00  from holding Consilium Acquisition I or generate 0.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Consilium Acquisition I  vs.  Da32 Life Science

 Performance 
       Timeline  
Consilium Acquisition 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Consilium Acquisition I are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy essential indicators, Consilium Acquisition is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Da32 Life Science 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Da32 Life Science has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Da32 Life is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Consilium Acquisition and Da32 Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Consilium Acquisition and Da32 Life

The main advantage of trading using opposite Consilium Acquisition and Da32 Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Consilium Acquisition position performs unexpectedly, Da32 Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Da32 Life will offset losses from the drop in Da32 Life's long position.
The idea behind Consilium Acquisition I and Da32 Life Science pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance